NCT00867126 2018-11-26Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With GemcitabineUniversity of Texas Southwestern Medical CenterPhase EARLY_PHASE1 Terminated6 enrolled